Regulation_NN
and_CC
specificity_NN
of_IN
MNDA_NN
expression_NN
in_IN
monocytes_NNS
,_,
macrophages_NNS
,_,
and_CC
leukemia\/B_NN
lymphoma_NN
cell_NN
lines_NNS
._.

The_DT
expression_NN
of_IN
the_DT
human_JJ
myeloid_JJ
cell_NN
nuclear_JJ
differentiation_NN
antigen_NN
-LRB-_-LRB-
MNDA_NN
-RRB-_-RRB-
was_VBD
observed_VBN
specifically_RB
in_IN
cells_NNS
of_IN
the_DT
granulocyte-macrophage_JJ
lineage_NN
in_IN
our_PRP$
earlier_JJR
reports_NNS
._.

The_DT
specificity_NN
of_IN
MNDA_NN
expression_NN
for_IN
cells_NNS
in_IN
the_DT
granulocyte-macrophage_JJ
lineage_NN
was_VBD
reexamined_VBN
in_IN
cell_NN
lines_NNS
established_VBN
from_IN
patients_NNS
with_IN
Philadelphia_NN
chromosome-positive_JJ
chronic_JJ
myeloid_JJ
leukemia_NN
._.

Cell_NN
lines_NNS
that_IN
expressed_VBN
MNDA_NN
exhibited_VBD
myeloid_JJ
cell_NN
features_NNS
and_CC
granulocyte_NN
or_CC
monocyte_NN
differentiation_NN
could_MD
be_VB
induced_VBN
in_FW
vitro_FW
,_,
while_IN
cell_NN
lines_NNS
exhibiting_VBG
properties_NNS
of_IN
very_RB
early_JJ
stage_NN
cells_NNS
or_CC
multipotential_JJ
cells_NNS
did_VBD
not_RB
express_VB
MNDA_NN
._.

Cells_NNS
originating_VBG
from_IN
cases_NNS
of_IN
Burkitt_NN
's_POS
lymphoma_NN
were_VBD
negative_JJ
._.

By_IN
contrast_NN
,_,
three_CD
lymphoblastoid_JJ
cell_NN
lines_NNS
-LRB-_-LRB-
immortalized_VBN
in_FW
vitro_FW
with_IN
Epstein-Barr_JJ
virus_NN
-RRB-_-RRB-
were_VBD
weakly_RB
positive_JJ
and_CC
MNDA_NN
was_VBD
up-regulated_VBN
by_IN
interferon-alpha_NN
-LRB-_-LRB-
IFN-alpha_NN
-RRB-_-RRB-
treatment_NN
._.

As_IN
we_PRP
reported_VBN
previously_RB
,_,
MNDA_NN
mRNA_NN
level_NN
in_IN
adherent_JJ
monocytes_NNS
is_VBZ
elevated_JJ
by_IN
IFN-alpha_NN
;_:
in_IN
this_DT
study_NN
,_,
we_PRP
further_RB
assessed_VBD
MNDA_NN
expression_NN
in_IN
in_FW
vitro_FW
monocyte-derived_JJ
macrophages_NNS
._.

Three_CD
additional_JJ
agents_NNS
-LRB-_-LRB-
endotoxin_NN
,_,
phytohemagglutinin_NN
,_,
and_CC
phorbol_NN
ester_NN
-RRB-_-RRB-
and_CC
other_JJ
conditions_NNS
that_WDT
affect_VBP
function_NN
,_,
cytokine_NN
production_NN
,_,
differentiation_NN
,_,
and\/or_CC
growth_NN
of_IN
monocytes_NNS
were_VBD
examined_VBN
for_IN
their_PRP$
ability_NN
to_TO
alter_VB
MNDA_NN
expression_NN
._.

The_DT
results_NNS
varied_VBD
with_IN
the_DT
agent_NN
,_,
cell_NN
type_NN
,_,
and_CC
stage_NN
of_IN
differentiation_NN
._.

Changes_NNS
in_IN
MNDA_NN
expression_NN
occurred_VBD
slowly_RB
-LRB-_-LRB-
hours_NNS
to_TO
days_NNS
-RRB-_-RRB-
,_,
suggesting_VBG
that_IN
MNDA_NN
could_MD
mediate_VB
changes_NNS
realized_VBN
over_IN
a_DT
long_JJ
period_NN
._.

The_DT
results_NNS
also_RB
reveal_VBP
a_DT
discordance_NN
in_IN
certain_JJ
MNDA_NN
positive_JJ
cells_NNS
between_IN
steady-state_JJ
levels_NNS
or_CC
changes_VBZ
in_IN
levels_NNS
of_IN
protein_NN
and_CC
mRNA_NN
indicating_VBG
that_IN
the_DT
regulation_NN
of_IN
MNDA_NN
expression_NN
occurs_VBZ
at_IN
more_JJR
than_IN
one_CD
point_NN
._.

Changes_NNS
in_IN
MNDA_NN
expression_NN
are_VBP
consistent_JJ
with_IN
a_DT
role_NN
in_IN
opposing_JJ
macrophage_NN
differentiation_NN
and_CC
activation_NN
of_IN
monocytes\/macrophages_NNS
._.

